Exclusive

Publication

Byline

Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand

Singapore, Aug. 31 -- Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasing contributions from innovative drugs, pipeline progress ... Read More


CanSinoBIO accelerates overseas growth as vaccine portfolio and mRNA pipeline expand

Singapore, Aug. 31 -- CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside progress across its marketed vaccines, regulatory-stage produ... Read More


DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion

Singapore, Aug. 31 -- Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-generation antibody-drug conjugates using its proprietary DUPA... Read More


Formosa Pharma files European trial application for Kadcyla biosimilar TSY-110

Singapore, Aug. 31 -- Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal study of TSY-110, its biosimilar candidate referencing the HE... Read More


Novogene to establish first Australian genomics laboratory at Cabrini Health

Singapore, Aug. 28 -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and res... Read More


AUScelerate and Shanghai Center of Biomedicine Development sign MoU to advance life sciences innovation

Singapore, Aug. 28 -- AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build collaborative links and open-up new market opportunities f... Read More


DKSH expands pharma biz through acquisition of P.R. Chemicals in Thailand

Singapore, Aug. 28 -- DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (APIs) in Thailand. The acquisition strengthens DKSH Perfor... Read More


Singapore makes effort to close invisible gap in inflammatory bowel disease

Singapore, Aug. 28 -- Inflammatory bowel disease (IBD) can be deceptive. Over time, this unseen inflammation can damage the intestinal lining and cause ulcers, even before symptoms become apparent. Th... Read More


Korea's Samsung Biologics announces approx $2 B rights offering to fund next-phase expansion

Singapore, Aug. 28 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced a rights offering to raise an expected aggregate amount o... Read More


Longevity Life Sciences partners Mitsubishi Gas Chemical to expand cellular health platform

Singapore, Aug. 28 -- Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mitsubishi Gas Chemical to bring a pipeline of pharmaceutical-... Read More